A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Clinical trial NCT07226206 · RECRUITING
Trial details
- NCT number
- NCT07226206
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2031-07-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.